pharma-company /Medicinal products /Active ingredients

Rx · PZN 20048629, 20048612

COMIRNATY LP.8.1 3 µg MDV CON BUND

German trade nameCOMIRNATY LP. 8.1 3 -m63g MDV CON BUND

Active ingredientCovid-19, RNA-based vaccineSubstance (DE)Covid-19, RNA-basierter Impfstoff

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Highest known
purchase price (B2B)

N/A

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

COMIRNATY LP.8.1 3 µg MDV CON BUND contains the active ingredient Covid-19, RNA-based vaccine (German Covid-19, RNA-basierter Impfstoff). 2 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days.

Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
200486290.00.0N/A
200486120.00.0N/A

COMIRNATY LP.8.1 3 µg MDV CON BUND was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

More products containing Covid-19, RNA-based vaccine

SPIKEVAX LP.8.1 50 µg injection-dispersion in Fertigspritz3.6COMIRNATY 10 µg JN.1 MDV RTU BUND0.0COMIRNATY 10 µg JN.1 MDV RTU ÖGD0.0COMIRNATY 10 µg XBB.1.5 MDV RTU BUND0.0COMIRNATY 10 µg XBB.1.5 MDV RTU ÖGD0.0
All 31 products containing Covid-19, RNA-based vaccine →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. No purchase price is available to us for this product.